Cargando…

Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication

Echinocandin antifungal drugs, including micafungin, anidulafungin, and caspofungin, have been recently reported to exhibit antiviral effects against various viruses such as flavivirus, alphavirus, and coronavirus. In this study, we focused on micafungin and its derivatives and analyzed their antivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Shogo, Ohashi, Hirofumi, Akazawa, Daisuke, Torii, Shiho, Suzuki, Rigel, Fukuhara, Takasuke, Watashi, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958940/ https://www.ncbi.nlm.nih.gov/pubmed/36851666 http://dx.doi.org/10.3390/v15020452

Ejemplares similares

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
por: Torii, Shiho, et al.
Publicado: (2021)

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
por: Machitani, Mitsuhiro, et al.
Publicado: (2022)

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir
por: Torii, Shiho, et al.
Publicado: (2023)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

SARS-CoV-2 Omicron detection by antigen tests using saliva
por: Murakami, Kaoru, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Agents in Artemisia Endophytic Fungi and Their Abundance in Artemisia vulgaris Tissue
por: Maehara, Shoji, et al.
Publicado: (2023)

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
por: Wing, Peter A. C., et al.
Publicado: (2023)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses
por: Tamura, Tomokazu, et al.
Publicado: (2022)

Antiviral effects of micafungin against pteropine orthoreovirus, an emerging zoonotic virus carried by bats
por: Hondo, Eiichi, et al.
Publicado: (2023)

Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives
por: Nishiuchi, Kota, et al.
Publicado: (2021)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
por: Hijikata, Atsushi, et al.
Publicado: (2021)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19
por: Ichikawa, Takaya, et al.
Publicado: (2022)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Cardiac Safety of High-dose Micafungin
por: Stover, Kayla R., et al.
Publicado: (2017)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis
por: De Rose, Domenico Umberto, et al.
Publicado: (2021)

Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
por: Watashi, Koichi
Publicado: (2021)

Antiviral Effect of Candies Containing Persimmon-Derived Tannin against SARS-CoV-2 Delta Strain
por: Furukawa, Ryutaro, et al.
Publicado: (2023)

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
por: Suzuki, Rigel, et al.
Publicado: (2022)

Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication
por: Seitz, Tatjana, et al.
Publicado: (2023)

Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents
por: Hishiki, Takayuki, et al.
Publicado: (2023)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
por: Undre, Nasrullah, et al.
Publicado: (2014)

Micafungin in the treatment of candiduria: A case series
por: Kane, Lauren E., et al.
Publicado: (2016)

Are we near to the end of the standard dose of micafungin?
por: Agrifoglio, Alexander, et al.
Publicado: (2018)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kg8mnc135581rmrsibvh3sj4uv